Long-Term Overall Survival After Selective Internal Radiation Therapy for Locally Advanced Hepatocellular Carcinomas: Updated Analysis of DOSISPHERE-01 Trial
Conclusion: After longer follow-up, personalized dosimetry sustained a meaningful improvement in OS, which was dramatically improved for patients who were accurately downstaged toward resection, including most portal vein thrombosis patients.
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Garin, E., Tselikas, L., Guiu, B., Chalaye, J., Rolland, Y., de Baere, T., Assenat, E., Tacher, V., Palard, X., Deandreis, D., Mariano-Goulart, D., Amaddeo, G., Boudjema, K., Hollebecque, A., Meerun, M. A., Regnault, H., Vibert, E., Campillo-Gimenez, B., Tags: Clinical Investigations Source Type: research
More News: Brachytherapy | Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Liver | Liver Cancer | Nuclear Medicine | Radiation Therapy | Study | Thrombosis | Urology & Nephrology